{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.2-dev",
    "document_metadata": {
      "name": "Tau oligomers-Cytotoxicity, propagation, and mitochondrial damage",
      "version": "1.0.0",
      "description": "Tau oligomers-Cytotoxicity, propagation, and mitochondrial damage from Shafiei et al., 2017",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "authors": "Sandra Spalek and Charles Tapley Hoyt",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de"
    },
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20180106.belns",
      "GOBP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20170725.belns",
      "GOCC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20170725.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20180215.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns"
    },
    "namespace_pattern": {},
    "namespaces_uncached": [],
    "annotation_url": {
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {
      "PublicationType": [
        "Comment",
        "Research",
        "Review"
      ]
    },
    "path": "/Users/cthoyt/dev/knowledge/hbp_knowledge/shafiei2017.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "calcium(2+)",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "dextran",
      "id": "34c957a9a59d213b210f26c03eadcdb7ef07ac5d2c339ce611c6a9b764b8cfd64dbafe9281b5402f4e2e2706a5b6a2cec083dcc2c726b65edfe29137b88f4285"
    },
    {
      "function": "Abundance",
      "namespace": "GOCC",
      "name": "cell surface",
      "id": "9464e19cb2aff9e7cbee6c76ba8db7402367035656f23710258acfb2febc35ae9a15e414784d3ef58f3b4fa03284eb5b03dffbfd00fb7708cade64f9311feb51"
    },
    {
      "function": "Abundance",
      "namespace": "GOCC",
      "name": "neurofibrillary tangle",
      "id": "a74c48981c376e4906857d37cdf6514d087c78def0f0013c5609ad94b009e3e9afb18337c75f0454c449bbdf2aea4be787c1dc061fb1d87af782a63e23ac5ecf"
    },
    {
      "function": "Abundance",
      "namespace": "GOCC",
      "name": "microtubule",
      "id": "99a55995707cf30dd889347e34d44da717585b3c831ef4c475e874576e602a8658f599ef23826221a20d707996e33d5ab40ba8f007489b2efecd8f127641d854"
    },
    {
      "function": "Abundance",
      "namespace": "GOCC",
      "name": "microvesicle",
      "id": "c316b325eb3008696cf74064139926532c3a6dcb04682fc0aa3123ac792de733d4b42d9ca15320cda1a53f3ba3752488f256f5f7113b467e48a2786a973330da"
    },
    {
      "function": "Abundance",
      "namespace": "GOCC",
      "name": "synapse",
      "id": "d44864ba03c2ad5bd4127a4b20ef86e1cb161f5d78ec938577f080a63170ad91ce15e80471bda1fb1dc5f3f8474dcebbd63533df72daa46ceac700499cbc7bac"
    },
    {
      "function": "Abundance",
      "namespace": "GOCC",
      "name": "vesicle",
      "id": "93aa6b4feb9b21167fd4234e7feb75dd3379f7697ab140366e6ff850c7245e8d86aaf7743620c46532b6dc55c61077d49ba4918ac590f4f74f84d59c5dc36d9a"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau aggregates",
      "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau annular protofibrils",
      "id": "c5076c34453b4dea315ea714222a1aed5e86596cb1e243f7b59c9deb85949603fbbf287756eb348dfcbb64255b3e56535cc5a8f79a59266e0c89d1e227f0445f"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau fibrils",
      "id": "cd2dab27f628336ca0ed44605c7cd92f2fd119b914305cba845b06c61ab768ecf96cc32e4679b8ca5361f3e5cd3bd2418c91526348cc067d58282b812be1310a"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau oligomers",
      "id": "d4ceff8aa5a5d05770aaa29b828d003b85d64e7e5337c6624b7c5a84111845897462b589e7b259b0eed6bcfc63f34cdaf1f9b988c788804799aea026d8731d98"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "amyloid-beta fibrils",
      "id": "67b4c76bd9f06b116883a58eaa40e8453f2fda318ae9313477ebc24c6d04613ea373fdf611fd8a740de5a090826662d88c39f2ab166bca226cc8237cb0c71a1a"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "dense core plaques",
      "id": "6d6a4bc6ad2a0a2386d67fc40cff2fc6ffa0b0b670c5f3e2bf61344b4a606a700134639c9bfec52b10b34b9e8859a245be6b94bb8e1e0f3da5a7660c3e6342d4"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "granular tau oligomers",
      "id": "66a20baded47bebc2ecf355117a394b50659c3c5c5e09dcf236072a2d192c718fdb1ae423761ecd2b03e65caf534f456469a291822948187f24c47186737bee6"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cell Membrane",
      "id": "01ec7ffbcb8c9179057e9b0566861267a0a59f1b56f279101da5015908500b307bc7b168ef6d6540548d8fe99dd18a44e972e1682631a179a440ad4e5f662b4a"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Electron Transport Complex I",
      "id": "2ed8e91c658f93981992c15b662604abfe0c62856d25a4fd7066da4da3d650bfe8d98a30cf3ef4c2265e449c13993c9c55d64141b3071f6d25714cf659788f5a"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Heparan Sulfate Proteoglycans",
      "id": "1d57bfa5ee4dfb807decc83f2ecb11ff087fc01feabbcb80714b657b5c1b851e88657034da433646e0405f5db8b3f088a8bf099f6eb872371b1ea26980e17958"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Receptors, N-Methyl-D-Aspartate",
      "id": "bc0c849274509856f0839b39c84ee4c4d06be886e9c4a160c019e566da4f7b7da0f773b5326d9d72ab53f350fa5ff3371b3cf66ae89e844579e4eb6102565963"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Exosomes",
      "id": "8c18d3f2857c6224d1a64c194590d5feb768c6b5702894793347106f0934e6decd18cf29c425ecfaa587372a5c68f3c16a00ba0691d54652a5fa1872105f09ad"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "ATP synthesis coupled proton transport",
      "id": "8063ab328f318ecca0b57872ea428b5a19f3d005e75f81ff366d4f873e43b0b0cb1ac6cb7c4219bd5814f26cc572f4a3cf4928c8b16c0e91eabfccecba6d623e"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "anterograde axonal protein transport",
      "id": "d4e72ce85a70e84d2b598695e4d2176c3e764071d6179e406c44636188267bf31dddfcc66e0c70aea8e36a2604fd0bc921839d27aa408af9f522ad41559c8ee6"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "axonal transport",
      "id": "a6dbd77b98d99bdeff16a73cc0eb417359152f341b34500e3c4afca4ae8849ad891b721737f259ff50602760f9db92f53a40910980aa476a38cbea57cf697be8"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "cell death",
      "id": "e9c34894f8168b5203457e34ed316d9efdb8fd1ea105df0abd94b75fd8903b1e251ea98a878c68eea11861a5298f3a2cd1f1d1a9fa96e59cb4e504b9d5c71780"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "generation of neurons",
      "id": "36ee87c177d078b9b97499b54bf57f4829bb11a40327aa1a3baff6d140105c7518b22960e66bf212040b09e0ef61883318230b3eee46beeb64e47f134f062ed2"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "intracellular signal transduction",
      "id": "a2663b61abf87e8977cb006c7387e1a64c3238acbcd2c5687b730375f492e13599c25f08854f8ea6de1dcd19d1b11c833d09540b1691ac9aea4ff073d377ccbf"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "maintenance of synapse structure",
      "id": "13f9bdfce6263fae33e97ca50ae551c42f71ad1ecc6d5358ecdc382560d8d4218ba3424e4fb9537c5a98b606d06ebbd35c5347d54e58bca5647b5f65fcc8c7e2"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "mitochondrion organization",
      "id": "670e1ac3d475018abb6cc3e1ab2da2215909876e48c314e30b8502ee8d54b9850d026cb7ab2f99d5b5370c0cd0cdaabab88a160659d209987b16df31c47ddd56"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "neurofibrillary tangle assembly",
      "id": "80513d4ba9f06faa2af3b70ac6ed2dac3c37e1911f47cc62c000f38207f81e566155564b6f7ce42acd95df06cba247ced8c3828686602916255b83c2df91972b"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "neuron death",
      "id": "7a2f309b1d4a7c1ab86704418e6cffe1e917c5d1d842312e825776263f2ae593e2d871381b4a4bacf2efab95f6f8e1d9264f5e025c7676621a1e72a9e74d7c85"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "synaptic signaling",
      "id": "d7910670828b20e894ecb64805e17d1eac46df7a1cc7e0d80ad79dbf9c8e89a9b99aacbd1fd3975e2d5a965154ead98504863585eeb4b056dcb76d62ac863932"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "behavior",
      "id": "6864ae785bef15d653d04b551290d756c7c9a58f46d65d3bbb5f9c510374d52f44fdb2feefd03213f84144ec1171dd47545193f0c28b4e16c8dee0255eca7d69"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "cognition",
      "id": "7085c04c66ff00d9ede4223662139766ae23124164f0ef453fdb23a5605c09df1809749b89f32471228956018a87d82e70ba03f41ce127eb1e49a4d7b1519884"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "endocytosis",
      "id": "fb96737a7ca418e1b347fed199711c91bad7e873f247b68bfa7ffaad5ac75033a120db50d95fb3f59a43da0eadd5e6b2fa8507617b2911f79894c44758856103"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "macropinocytosis",
      "id": "d792030d3cfaf74f2741069893073fb7af61b702f9f820d9daa876bf647c95ad24505a695b705d01a676a1d2703c1c42411950da3d59338d8c772916fd4df7dc"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GOBP",
      "name": "memory",
      "id": "2c0be3c3d7742f81a705f9ed3b9ae8ad529994d220b57b3c46cb1641073373cb3579b3c8ac29e9512cf6f3e2fd2207d508591b3c588d51484d8f1a21d05f1c8b"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HP",
      "name": "Neurodegeneration",
      "id": "96f5a3bbd33a722b2760c6448efdaabb70ed3e96434c786a9ad70ca7eb89b9585204c9e8df72a4ab1b5c7f617a36f919bde50523c31467d62a4842b479ddd805"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Cell Survival",
      "id": "abeaa000ab588015eac485dd605b78602795a7e237f3b097d8148a27fa3ebcc7a221d318d0399960d9f10cf194fbc9c29f41a2a8ed8c332b09f4b79680170b61"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Neuronal Plasticity",
      "id": "2faf5537d897c15a7721d74776d992d5a44ac80a8ff72cf1807a20f5d844c7812f98e952f4a085b30bac7a44a23fd44f51478048b615422b5fc54b6c05d74cb3"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Aging",
      "id": "175e5d777b693461a2f6189ec21aa1f8324f054bc8acc641df82819a4c04776202053094a1c12915bdfd2244a6a5f639b7008b7f8e9a5ffea3c3b8aaa255d1b9"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "GOCC",
          "name": "cell surface",
          "id": "9464e19cb2aff9e7cbee6c76ba8db7402367035656f23710258acfb2febc35ae9a15e414784d3ef58f3b4fa03284eb5b03dffbfd00fb7708cade64f9311feb51"
        },
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "Tau aggregates",
          "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
        }
      ],
      "id": "a26fc0b51bb4fef4ad71cb1681446e7c6dabe50a1aa4e3f1b54082bd72678f4fd6d5803346fecc9e823d5220747ac99270c937b07d5dfc24ede9e53fef14ff7d"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "GOCC",
          "name": "vesicle",
          "id": "93aa6b4feb9b21167fd4234e7feb75dd3379f7697ab140366e6ff850c7245e8d86aaf7743620c46532b6dc55c61077d49ba4918ac590f4f74f84d59c5dc36d9a"
        },
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Cell Membrane",
          "id": "01ec7ffbcb8c9179057e9b0566861267a0a59f1b56f279101da5015908500b307bc7b168ef6d6540548d8fe99dd18a44e972e1682631a179a440ad4e5f662b4a"
        }
      ],
      "id": "707d9334942e62213e6bb0009f44c53ba50f6f43d002df1e6ce085780a6ae317bb710c200f125e49a549e911e739a12dabbf632d174748b82d576c73b91af455"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "Tau aggregates",
          "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
        },
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Heparan Sulfate Proteoglycans",
          "id": "1d57bfa5ee4dfb807decc83f2ecb11ff087fc01feabbcb80714b657b5c1b851e88657034da433646e0405f5db8b3f088a8bf099f6eb872371b1ea26980e17958"
        }
      ],
      "id": "a1b78015f1b18aa13fd1e802fbed94cee1ecbae3ba57560b2a478835cdcfab09fe19488d97dafd8d520530a9275ff70db1814c4484605cda1f11e234a0e58ed8"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Receptors, N-Methyl-D-Aspartate",
          "id": "bc0c849274509856f0839b39c84ee4c4d06be886e9c4a160c019e566da4f7b7da0f773b5326d9d72ab53f350fa5ff3371b3cf66ae89e844579e4eb6102565963"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "aec8b769a6d200477a1953d85f04b29cc69e107e05b4239578269c033a77927a0946092a5d316d423be0ab41bdcb6c7b795a7a0090f65135275102aa50e83e0c"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "APAF1",
          "id": "c03d1fe3f09014cab4d87b581d0a2b76c103883e2aa2e56cbb52ca3e800112d5519137f35203da849d6c984805146d9c876de7697d37cb45b35e67210c608d48"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CYCS",
          "id": "18cad379a6a2e954cf3453bb000c42de777b83b2e638a8b3f3ce03ae93e2edabd6b794d6283d05bb292ed583113d090155b3e6a908fbcebcfa126041d9bb1e03"
        }
      ],
      "id": "bef65a3430a448d69693e313ec9f9b720bf417797b46fdcef17d1695c7cd98f8895bf10c1d56d41e2ef62ef26835f95abe9c81c9b11725656aed110e085d5e12"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRM1",
          "id": "962b8a84d274a6e78416261efc2137bcf03c8035a7be3138736624f9c08fe9ae92738ac20d9edd54a6ace6ff161f28793df367f2e084e2837fd799e530fddbbd"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "263c570147e0aae94be6034164624446d5445b68896b00ca6f5228935d80e01bfe7f4e53e5e73723b8490f41fc9a22a9bb2ac36f525ea5c604bf6f4a9f57588e"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRM3",
          "id": "321acd12eb1b51bc2a14b21c01d30c83c6a4ce5c3255ef3cf2690b65596f9594c541dc6fe9a23210d952a2fdac2f2d05aa91e4299d1942926ea0932119e338ff"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "edaa087c67a8f25e6da5c4a58ced17a3fc92d4d2d5c6985b0ab2bc52aca81fe4806bc8eed009a8ac48284019040adac115b282ddad4862ff7c10a7e74c8418ba"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "DNM1L",
          "id": "7ebc68a26ac8bfa78b1f334086d149d73d73c9e5642ff2bfe0a5e55f73de9a80bc506ec1564cb081966bf84ea746ffb872a48e9b7255c57fc51b1a0d03d2ff83"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "ba9d80a41b3ba6d55e0e78dc04ced320ee20818e43d4cc03d75729df94e785dd432a95f1730ebdd6f2ecfa06ee255c6a3a0c816920b48e318845a51ba40f24a1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "APAF1",
      "id": "c03d1fe3f09014cab4d87b581d0a2b76c103883e2aa2e56cbb52ca3e800112d5519137f35203da849d6c984805146d9c876de7697d37cb45b35e67210c608d48"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CASP9",
      "id": "4f7b456ec0d9c86a9362a8101f8ec125d5fc4356161d4b470963ed9799df4f916d6ae2d7882fe2a66a845d07acebe126a8ae8bac90074ea5a63d0ed44e233279"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CHRM1",
      "id": "962b8a84d274a6e78416261efc2137bcf03c8035a7be3138736624f9c08fe9ae92738ac20d9edd54a6ace6ff161f28793df367f2e084e2837fd799e530fddbbd"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CHRM3",
      "id": "321acd12eb1b51bc2a14b21c01d30c83c6a4ce5c3255ef3cf2690b65596f9594c541dc6fe9a23210d952a2fdac2f2d05aa91e4299d1942926ea0932119e338ff"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CYCS",
      "id": "18cad379a6a2e954cf3453bb000c42de777b83b2e638a8b3f3ce03ae93e2edabd6b794d6283d05bb292ed583113d090155b3e6a908fbcebcfa126041d9bb1e03"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "DNM1L",
      "id": "7ebc68a26ac8bfa78b1f334086d149d73d73c9e5642ff2bfe0a5e55f73de9a80bc506ec1564cb081966bf84ea746ffb872a48e9b7255c57fc51b1a0d03d2ff83"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 421
        }
      ],
      "id": "8b25c8b7b0159f1821bf6c55053a322d059a772b58309bcc21a16ddfc66065efbeddde9feda9f161d2c32cea7167ddc7040e6cd14d1cded26e67c640af3f5fce"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "frag",
          "start": 421,
          "stop": "?"
        }
      ],
      "id": "5aca6614f073cf27b18a629a3d665d8d7b67580d6d4038f16dabdc811fc39d9b8298531cf54e66fa6e48f9016207376261b903587519495d90cebddccc861a72"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 396
        }
      ],
      "id": "233ebce30d7505cee42acc956f9d268e5b725e14853bd56fab3b87a93a4e0c8141a6fdec062d10e9c4924f6e13a61184600872c2f5080656e3ca27227eb4cb93"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Thr",
          "pos": 181
        }
      ],
      "id": "820b780f4d0abcec3e7acc5219d0bf0d994ff6274f5579982e73ee0337a49544a879a9cfee0a37d3bd9d93b5e34382eb0c319ef7f7c31ff6f74841594b6fb17a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PRNP",
      "id": "97023c238092f75f952ae0785caba6d1454099f27405c7e582078f2f49f5ef146e0c8eb3a1c25a63781a21e5d83689e958397e3115d98e65cf8c5a2ad9c7bffd"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Brain Injuries, Traumatic",
      "id": "045bae6eea134b42537774fcd702c7450a66a9f19fedd90aed63fed01468978b1449afeb8e68a5bf609df87bb9d2bc4613280f3a7225911fb029ca78ab2f02d7"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Cerebral Amyloid Angiopathy, Familial",
      "id": "43aed35d6564667fc72cf3b8486844a9f9a7420b186f34bc7de74fe1850e98f93ebf44a767560d04c6e48c8e0eca887410cff422789e5cc96f212330a64ae91f"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Frontotemporal Dementia",
      "id": "65b349369f9bedd1a6220b3923747475397a886cb45f96f65e9aad66d695cfd560911459bd006d087e0ee4cbf06d8829549b3e32854fe68093e2b5834049d726"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Plaque, Amyloid",
      "id": "888c33ecabc995942e605aace0106831b95c6e6d4eb99ee4ac4c1de25ff7c58c0cb67b5e941c2d3f3a399aada51a34de03850a43011389d2ab7dae07536cea30"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Supranuclear Palsy, Progressive",
      "id": "06432576e845db5beb8ae7a4c0ae23454b691ca1773f3467bbd58f6ce3d484e768e57b6abbc21258bd43941d8ed10874fa0d45b24d91638ed7e42dcb0e5c7dd1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Disease",
      "id": "b0824aadbdd87d5bf92d70094a8d0b9561e9a4f29bdc787c64968472c4a7d4e58b9c02006f2323336a00d678780c00be7d6e8e4648885849adb11396949b48c9"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Tauopathies",
      "id": "d2087b32a76c528191af8305652f4664cbeb31b3f4e3f9627aaf61259e271f83a7d1be65f83e9178ccf3811482ece65b940fe4ce9a714b2281f705c0d499502b"
    }
  ],
  "links": [
    {
      "line": 52,
      "relation": "increases",
      "evidence": "These share a common histopathological hallmark known as neurofibrillary tangles (NFTs) that consist of an accumulation of fibrillar tau deposits initially produced from tau protein aggregation (Ballatore et al., 2007)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 8,
      "target": 3,
      "key": "d19bcbe31add7dfd842590cfaf1088102082a0d635928539b13df3fccbd50b329ad5f2f7fdafd10936b2356beb0f11bb641e4d4aaf754c4ddb599d10c6d433c6"
    },
    {
      "line": 160,
      "relation": "decreases",
      "evidence": "Additionally, studies have discovered that aggregated tau inhibits fast axonal transport in the anterograde direction at all physiological tau levels, whereas tau monomers have had no effect in either direction (LaPointe et al., 2009; Morfini et al., 2009)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 8,
      "target": 21,
      "key": "1a8e85dce60223c384008629464d969700f5cc538ec3f74ff639eae96386135eeb3349aa8fcfbae83568fa2463b7d1f2f47122f940de675be995a52bb1c217c2"
    },
    {
      "line": 234,
      "relation": "association",
      "evidence": "A recent study showed that neuronal networks facilitate cell-to-cell transfer of tau via synapses; using a microfluidic device they demonstrated that decreasing synaptic connections weakens tau transfer and the subsequent aggregation on the acceptor cell (Calafate et al., 2015)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "source": 8,
      "target": 38,
      "key": "4fa13853b95269a25cd326cb2a81d8f7e67d29227b9d265dd9979526a894ba3893cfbbad2e6c0b68dee9472aee0d8909b0e8724471e8911cb3d27f952dfa3c5d"
    },
    {
      "line": 295,
      "relation": "association",
      "evidence": "Significantly, evidence suggests that tau secretion is partly mediated by ectosomal vesicles and that pathological tau accumulation in cells leads to a deviation toward tau secretion by exosomal vesicles (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 8,
      "target": 54,
      "key": "80c13924844417b2261f09433d5ac666b0ad7253430f66157559b62a0567de3fc56017cefa42b05dad0d5a69267cb3743121e61d3871d73ba438c1eb3dc0f0ce"
    },
    {
      "line": 333,
      "relation": "association",
      "evidence": "Evidence shows that tau aggregates colocalize with dextran and HeLa cells, hinting that internalized aggregates are transported in endosomal vesicles and passed through the endosomal pathway to lysosomes (Wu et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 8,
      "target": 1,
      "key": "cd525437dba0b663bcd194b676b8aa9e85b7365995ce4f9d08268ccb9410983ba0ff75c61044f690c5fae182a40110e390cd98f38c99af5252fc8b9318eba461"
    },
    {
      "line": 74,
      "relation": "positiveCorrelation",
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 3,
      "target": 61,
      "key": "4e84d0bea3d741e7e29319b356ba2894923b1b08a0053f0c48ce1086475d6130f9dbdadcd60e8f0638f875e8435b4c50cbb228a0f7cb4b93a9c58265fc0f3b7e"
    },
    {
      "line": 58,
      "relation": "increases",
      "evidence": "While functional tau is an unfolded monomeric protein that stabilizes microtubules, regulates neurite growth, and monitors axonal transport of organelles (Medina and Avila, 2014), dysfunctional tau acquires a new toxic function",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 54,
      "target": 4,
      "key": "b624475a998e40a11ae432dacc7885a79ec224fb6e480186ac0818c228ca827bc84e43c5b734c9cff130cb8bb4d32e0c9e0bee9fa4012f3ebd5df498174492a5"
    },
    {
      "line": 59,
      "relation": "regulates",
      "evidence": "While functional tau is an unfolded monomeric protein that stabilizes microtubules, regulates neurite growth, and monitors axonal transport of organelles (Medina and Avila, 2014), dysfunctional tau acquires a new toxic function",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 54,
      "target": 24,
      "key": "1c140ea695c34f8bddd8e565f0faefec6427bebf73dc279a1ff1e621ad03fb7c90d90bf5b4dee001c64649e991f937ccd5a601f6fee8777bb9d362eee2ad98be"
    },
    {
      "line": 60,
      "relation": "regulates",
      "evidence": "While functional tau is an unfolded monomeric protein that stabilizes microtubules, regulates neurite growth, and monitors axonal transport of organelles (Medina and Avila, 2014), dysfunctional tau acquires a new toxic function",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 54,
      "target": 22,
      "key": "a1f3858197c7fc979fea50b8f69959eda239095dcd37a470fe265932d3e441d79b70c2ab790b21844909b35e3ffefbc9d62ad53526223f0520c8a7ef77deade7"
    },
    {
      "line": 88,
      "relation": "increases",
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 36,
      "key": "081289c4a85694fb7d235cb3471e627aaf0ee402d875c62f5596d2f5f180dd8ba135b7d6b820118cad2db63a904473a56dedb231010cad815cccfc587f157433"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 23,
      "key": "49519bb3dc3e0e6df576883d38554bfadde1e6a890b0dc2403ed97b96b97ce634fccf63f8c235f16b08a83f38d379fd2c75e38573c9bfdf9f2bef8dea8132ec3"
    },
    {
      "line": 90,
      "relation": "association",
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 31,
      "key": "f87f698d41caf4905d22e2c58444afdbf3c5ee79af1219ed9602422f180ab5f59e26b260e01ae293e9a0fcfffbf9921433ad86f420457190c56d939d400578f0"
    },
    {
      "line": 91,
      "relation": "decreases",
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 30,
      "key": "dc46390c16a1579581ef819592deb7c1438c5f6a80fe5229297f7dc2e11b03887966d3e9cf32d9eff4c1cf2af6e56d75cad5062de3449454079c983a0675a958"
    },
    {
      "relation": "hasVariant",
      "source": 54,
      "target": 57,
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48"
    },
    {
      "line": 200,
      "relation": "association",
      "evidence": "This hints that tau plays a role in monitoring intracellular signaling pathways (Pooler and Hanger, 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 54,
      "target": 25,
      "key": "a42c7242d50cd8d4360867724e2c6cad54a510c13067bcb7fe53adb0059747e7a468a507c5392734a2b164ff8266099073a051eb9295d455740fec48b96049df"
    },
    {
      "line": 208,
      "relation": "positiveCorrelation",
      "evidence": "In AD, the quantity of tau identified in the CSF increases with disease progression (Hampel et al., 2010). However, the mechanism of tau propagation from the brain to the CSF remains elusive",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        }
      },
      "source": 54,
      "target": 61,
      "key": "b3a5845618915787f0bc1d7bc5508ec860e7ba286d3cacc06c90f730f9e832a5ee8542dc5f9b16fc7e8f1b6d2fe9a032f5aa95f994fb48730e6f55f34b04988b"
    },
    {
      "line": 272,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 54,
      "target": 61,
      "key": "05a3f9606685e2a162765069298423536598de7698855b9b5653f8a14fc9562ccb0381522766f316fde3e6fadb5e8e6240254e633e31744b497e7dfcff8a0287"
    },
    {
      "line": 224,
      "relation": "association",
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "subject": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "axon"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "cell body"
          }
        }
      },
      "source": 54,
      "target": 39,
      "key": "62c9eb1ca12e2d1e5df130d930c53051c1022b67821249a3bf078ddb82d6491a0c1a4a308a2d0734d772bfc298fdbebd930fefb3c276e100d5fd3213d481ac5c"
    },
    {
      "line": 225,
      "relation": "association",
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "subject": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "axon"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "dendrite"
          }
        }
      },
      "source": 54,
      "target": 39,
      "key": "f805235bb9165ef31e6574c4f1c43275c11ac5d496b6bf9713f0a636ccf1681cac4f1bbdbfba92ba01bed3781065340bd3fd10d5df7f6e35f70f7c3268b85e16"
    },
    {
      "line": 248,
      "relation": "association",
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        }
      },
      "subject": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 54,
      "target": 19,
      "key": "dbbd62c3b2e439f9546cb4bc30318dd81d60e8826c4fd2844a157fece7093bf7fa84677eaca7229ad031a3f214f7dd54138304c064d6ad823d7b258dc45f6e2d"
    },
    {
      "line": 249,
      "relation": "association",
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        }
      },
      "subject": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 54,
      "target": 5,
      "key": "ffaeb6ef9d5e283370c0c23c9f73dfb42fdd2d77900636d9eba6ca5339660b458eb52f1b6340df81189d3caa95915fae8dc04924322cc7bce77a82f34f26601b"
    },
    {
      "relation": "hasVariant",
      "source": 54,
      "target": 59,
      "key": "213a46846a62680cc05d2ed2719a937dff6a8fabf62eab17e78a50282285efef229adb3605d9160e01e020062742249185e5f3756340776a7a7cac3951c27468"
    },
    {
      "relation": "hasVariant",
      "source": 54,
      "target": 58,
      "key": "09505215df0db1264915198df6f54ea647eb376b6ede05f22846b2d289a2907fa049769b8eb45a919e706a2eb7c7a96704537753eeb5e7c30a012888cd5296de"
    },
    {
      "line": 275,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 54,
      "target": 64,
      "key": "813ea8a4da016bf8cc3fe09cfb10a9c9ba1f5ba739573165fab6cc7cfdd3d55e17f38a3d69fc760456aa864d4262100cc7709304c8daa4a4adc5728da46a0bb4"
    },
    {
      "line": 295,
      "relation": "association",
      "evidence": "Significantly, evidence suggests that tau secretion is partly mediated by ectosomal vesicles and that pathological tau accumulation in cells leads to a deviation toward tau secretion by exosomal vesicles (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "subject": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 54,
      "target": 8,
      "key": "36e22a2b072a1d39dc4bdac9bf2dfe09dbb64bd74b4dbdb48ad88aaad53c3997956d05a310d2c3348853c360d059860a22734a624efabbb602b8462d0fd235ec"
    },
    {
      "line": 301,
      "relation": "increases",
      "evidence": "Tau may be endocytosed, promoting an increase in intracellular calcium that results in neuronal death",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 54,
      "target": 0,
      "key": "d22c55d80b1422c9008b010017543f45dbe4ba7950d15f1c7bc2013b75a39c98e89520a3802a74e09ac652bb9511ac32aa744378005b0f7274637c67e746daf7"
    },
    {
      "line": 303,
      "relation": "increases",
      "evidence": "Tau may be endocytosed, promoting an increase in intracellular calcium that results in neuronal death",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 54,
      "target": 29,
      "key": "d87f7164297aad1ac87ec00fc35c21771d893a4b017ff41faa219b87c44fb02e1001c2215cd80778100c46d9594dd25d2f9d2d7248c347511ff9ff09323e2d28"
    },
    {
      "relation": "hasVariant",
      "source": 54,
      "target": 55,
      "key": "6a126d8365bb4508ff549b732044ca4965cfb7ea484cbc10ba7c1e8409265ac7368054834e8057df94d0a80c3e5ede01b827a4a1f14d003a6a485f2561808baa"
    },
    {
      "relation": "hasVariant",
      "source": 54,
      "target": 56,
      "key": "032b78cbd668c7dc3b2fc23ad040069dfbf06bfd902f471b98dc9d3a0e3eb6f99043e56051bef53aab35f82f58c1fa671ab4f5f882f3d67529588aa31bd8e3a8"
    },
    {
      "line": 66,
      "relation": "association",
      "evidence": "In AD, tau pathology and neuronal cell loss coincide in the same brain regions, and as brain dysfunction progresses, NFTs are found in greater anatomical distributions (Ihara, 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 68,
      "target": 29,
      "key": "cdd10da84e89cd76fa75d9cd705e15e26ecf15aecd11041bceddee265b27e4859f5eaed7aebeb8e7b999615b5397d0c44e1c5845872fed003ccc600c1d687c8a"
    },
    {
      "line": 392,
      "relation": "association",
      "evidence": "Hence, tau APFs may play a significant role in tauopathies by linking pore formation to cell death",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 68,
      "target": 9,
      "key": "d95aa63fb048d4664f064608ffbdfed1b3bbf5852c2904948d9ae5d13d9232a4e6ca39e3f6acb2fb3dfa6dd691927bdc3e86c143f5dbd0aaa50ab8a5027d527c"
    },
    {
      "line": 66,
      "relation": "association",
      "evidence": "In AD, tau pathology and neuronal cell loss coincide in the same brain regions, and as brain dysfunction progresses, NFTs are found in greater anatomical distributions (Ihara, 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        }
      },
      "source": 29,
      "target": 68,
      "key": "5e4a1d1d4865af90810d6aadbeb8463ac55e52a0234c6ac93092a14fa78a0eccb60f9d57669a3ea15eeae34bce60e23254c8609520e9c32a2a40f07d76f34c0d"
    },
    {
      "line": 73,
      "relation": "positiveCorrelation",
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 29,
      "target": 61,
      "key": "6433ee781c801769b9f330ff2db80e2c2005083a22b7b29e46877e553e35a0a7bbdb83abcc60c081f50bb3c55514e120ae1cdf575bea12d1fafe49aa840ea85e"
    },
    {
      "line": 73,
      "relation": "positiveCorrelation",
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 61,
      "target": 29,
      "key": "cf705ac5ba662cc1232aa02aa09d8467ede0664d9a2e15db03671f9f6fb659d2a124e7081a0e52865b4c3d7b6837b737d462cacd654fcd11126bfe57e9fe1adb"
    },
    {
      "line": 74,
      "relation": "positiveCorrelation",
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 61,
      "target": 3,
      "key": "0b57e599ec8c5505e969bb21c4055d628688e5ae4c10a0a1b5351cdfa8f1f36b640578a785c00f5fcf0750e622d7f00c64154096ca7f5e4338f101e55955e6e6"
    },
    {
      "line": 142,
      "relation": "positiveCorrelation",
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 61,
      "target": 11,
      "key": "cb45156ea6c732671a7f7f1fa9a083119b8e259a89160e186b1bbc4e4821b197d641eabe66c568ecfd4296a7a8a3747940cc5a7f2cba82e44c5601b1ae676c27"
    },
    {
      "line": 208,
      "relation": "positiveCorrelation",
      "evidence": "In AD, the quantity of tau identified in the CSF increases with disease progression (Hampel et al., 2010). However, the mechanism of tau propagation from the brain to the CSF remains elusive",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        }
      },
      "source": 61,
      "target": 54,
      "key": "4af24d76189822a2d81015e80ca46c40efc3873cd53b531453eff1d3e7aa9823d557a8ec83d2d24fcd971fdae15bfc7f538ea444ccbb3d468db0f7fe1120d415"
    },
    {
      "line": 241,
      "relation": "increases",
      "evidence": "In AD, tau pathology has been found to spread from the transentorhinal cortex to the neocortex in a sequential pathway",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        }
      },
      "source": 61,
      "target": 54,
      "key": "3bf4ad4fea32dc5db4ec9ecfde3885792a2a25e2f085f13216c2ca117e1dad77e1e2b94f465afce13b4b4aafb63a94b6395985c42d8f221e8f89e032df2e6243"
    },
    {
      "line": 272,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 61,
      "target": 54,
      "key": "353108f9e6dabcfd62f9c3efbef599eb1e2c4e98e83930b2c44cbfefafaf309fe6672017e6a579be82422c2ccc0888caea473d5323f5d480f430215e2da9ef05"
    },
    {
      "line": 273,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 61,
      "target": 58,
      "key": "3d870450c13eb5a58fef4057083f58d94548c031b2789f2bcfb355b8ae439ecd294928367b3a8d193744ba8cdfbf9c0bd57cb4ec380a4a2f7368fbfbfe3962aa"
    },
    {
      "line": 274,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 61,
      "target": 59,
      "key": "849552bd514130e0a29c3fe84e2ef504e81aac4e4dfa268c8c58fa198be7c2aec388a13ad696133c79ced17d756f1d31ec719aff94d99a31c683156f5b4f0dc8"
    },
    {
      "line": 216,
      "relation": "decreases",
      "evidence": "Recently, tau was discovered in the interstitial fluid of awake, wild-type mice, suggesting its release by neurons in the absence of neurodegeneration (Yamada et al., 2011)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Fluid": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 36,
      "target": 54,
      "key": "443891f2792d3eee28381e38c2c5661f3e43824523051dd33eead4dd3a56c6d6bbd221c9dedceef5d165b64d68273001d09eb3b68192ade6a1b06edeebf81108"
    },
    {
      "line": 90,
      "relation": "association",
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 31,
      "target": 54,
      "key": "50e07480c51c25d01f3749de52240f59835f96294aebde165aab677d87a56c506f0b63a136fbfaac59f11910fa3fb4f2e62fc012e34f59f68bd23b18d1895e05"
    },
    {
      "line": 98,
      "relation": "increases",
      "evidence": "While evidence indicates that these deposits are not toxic, many studies suggest that the tau oligomer, an intermediate entity, is likely responsible for disease onset",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 67,
      "key": "fadb4b70180820cb26d9fb7e85df8ea3f54c0cffd2a86077e4ceb6ecf03a123fee6bcb6e2a20bc0dfbf648405bce8b1bc79bb260561014e0300f955b9d8c1797"
    },
    {
      "line": 120,
      "relation": "increases",
      "evidence": "These tau oligomers potentiate neuronal damage, leading to neurodegeneration and traumatic brain injury (Hawkins et al., 2013; Gerson et al., 2014a, 2016; Sengupta et al., 2015). Moreover, they have been implicated in synaptic loss as shown in studies of wild-type human tau transgenic mice (Spires et al., 2006; Berger et al., 2007; Clavaguera et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 36,
      "key": "8f85d9e40e50c8a9581a487d2180d12335227708d4ffbf478a977506af6c75cd54e64ccecec54ee193bffa84930dbaf04705cb31b15441fa048c68af410dff32"
    },
    {
      "line": 189,
      "relation": "increases",
      "evidence": "These studies demonstrate that tau oligomers may be the toxic entities responsible for neurodegeneration in tauopathies (Ward et al., 2012",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 11,
      "target": 36,
      "key": "66b5bac1c991924332c8c0cbcc5844f0f5d6df6f8e3076d9b65ab77b8a1e5cdfb667b2163f6cbb65746e7398f801bdf2881c57aba6f3b5625ccb497fdf772d86"
    },
    {
      "line": 121,
      "relation": "increases",
      "evidence": "These tau oligomers potentiate neuronal damage, leading to neurodegeneration and traumatic brain injury (Hawkins et al., 2013; Gerson et al., 2014a, 2016; Sengupta et al., 2015). Moreover, they have been implicated in synaptic loss as shown in studies of wild-type human tau transgenic mice (Spires et al., 2006; Berger et al., 2007; Clavaguera et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 62,
      "key": "b2f45dada6529c54e0e128f0c40b740d8752dcf37e9ed9f7ebce3a2a2b9b64d02a1dee7e555403ffbeb6865287b8a13dce9e6728bcbde05112fbcbb789d8871e"
    },
    {
      "line": 122,
      "relation": "decreases",
      "evidence": "These tau oligomers potentiate neuronal damage, leading to neurodegeneration and traumatic brain injury (Hawkins et al., 2013; Gerson et al., 2014a, 2016; Sengupta et al., 2015). Moreover, they have been implicated in synaptic loss as shown in studies of wild-type human tau transgenic mice (Spires et al., 2006; Berger et al., 2007; Clavaguera et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 6,
      "key": "b9a48c9eba41735881223fcbcb83845f8d9f437450fce7ed8123a4d3c7a98b9c8c7db8ba9f73f37533190e1e7b3d26dfb2da4f4f5dace4cbc6d81e574956d47a"
    },
    {
      "line": 129,
      "relation": "increases",
      "evidence": "When the oligomer lengthens, it adapts a beta-sheet structure and transforms into a detergent-insoluble aggregate with granular appearance under Atomic Force Microscopy (AFM)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 14,
      "key": "db781b88736cc67fc28ba6d5ee17ae9b9a1940ce611424b2658bb23dedb46e24f56e3be209c3fbd940720829a0404a4f63bf77743e0ca85f330f4ef757d6adfd"
    },
    {
      "line": 142,
      "relation": "positiveCorrelation",
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 61,
      "key": "f7a25a997094fafba97749f5a1807091367d7cf7f920a9629fda2839b23cb054ea580b76379c6670355dc8366397c5c6f4cb4bea66f878a2e62217389350f343"
    },
    {
      "line": 143,
      "relation": "positiveCorrelation",
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 66,
      "key": "49c231e2c8ffa1f480a2188fbb06afbed1460db8b3516ef80ca79c777083225b3c2168ece44f3fc36cbec057be888685a518f32317025bc1533f8b2435119db6"
    },
    {
      "line": 150,
      "relation": "decreases",
      "evidence": "When tau oligomers, rather than tau monomers or fibrils, are injected into the brain of wild-type mice, cognitive, synaptic, and mitochondrial abnormalities follow (Lasagna- Reeves et al., 2011; Castillo-Carranza et al., 2014b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 32,
      "key": "456dc2de0c686af90d8f2a808bdfbcdcf0773c839a64e5738a727432bac3c996232c04539bb2747faec306604df6b7a7c86c4474ef5f3e21b01c1d439702ea5c"
    },
    {
      "line": 151,
      "relation": "decreases",
      "evidence": "When tau oligomers, rather than tau monomers or fibrils, are injected into the brain of wild-type mice, cognitive, synaptic, and mitochondrial abnormalities follow (Lasagna- Reeves et al., 2011; Castillo-Carranza et al., 2014b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 27,
      "key": "7265bcc94d46571e3bb7c96fbab7752bed23da54fdbd4173ce8c05118dd3acec8ad5b772565602a9950862348984e02108c875afb19adfb8745ff86d0a0323b9"
    },
    {
      "line": 152,
      "relation": "decreases",
      "evidence": "When tau oligomers, rather than tau monomers or fibrils, are injected into the brain of wild-type mice, cognitive, synaptic, and mitochondrial abnormalities follow (Lasagna- Reeves et al., 2011; Castillo-Carranza et al., 2014b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 26,
      "key": "308289268bb62a49a9b9d1dff7e2097957df0ad49a38028f27c1a179b9fd5795c2d40646fdcfdc75ec55a2a3b92f3ffa9ef9e028b1d6638611b87a99b22ad9ce"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "This indicates that tauopathies progress via a prion-like mechanism dependent upon tau oligomers (Gerson and Kayed, 2013; Castillo-Carranza et al., 2014b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 11,
      "target": 68,
      "key": "bb66309c3e4676379f96f93770094f06d3555cd6e9195b7970027a25d9c54ce8cec76fa0e8cdb4056dff56cbc7a6e5c6601191040aa6c51a9bbeaaf1990d289f"
    },
    {
      "line": 188,
      "relation": "increases",
      "evidence": "These studies demonstrate that tau oligomers may be the toxic entities responsible for neurodegeneration in tauopathies (Ward et al., 2012",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 11,
      "target": 68,
      "key": "79cb9431b39dab04833c595929ff1a32a8522b8b179404d5d534f329d43030e99016a2b2a1102047dcb64e47c20828bc195035becee545e7849645596c0f83b2"
    },
    {
      "line": 174,
      "relation": "increases",
      "evidence": "With this concept, tau may be able to translocate between neurons and augment toxic tau components; in fact, evidence suggests probability of tau oligomer propagation between synaptically connected neurons (Gendreau and Hall, 2013; Pooler et al., 2013b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "neuron part"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "neuron part"
          }
        }
      },
      "source": 11,
      "target": 54,
      "key": "73de8f242df88db153e074defce0669319a090cc08b8a7b4cf49bc1264e7f0e3a4c42320ea04383f5837c3770507df70a3c2290da034fe3d778bd9ff9baf681b"
    },
    {
      "line": 182,
      "relation": "decreases",
      "evidence": "Further, mice injected with tau oligomers in the proximity of the hippocampus experienced immediate memory impairment (Lasagna-Reeves et al., 2011)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 11,
      "target": 35,
      "key": "24c68ef5df7aaff0c9984ecab0d6ba0931961e0ae33b128fc85202c5748048c6007efd43887ce35f696b32d2ed2688d06c2d98fc9619e666a5c8e6ed83d5bc76"
    },
    {
      "line": 386,
      "relation": "increases",
      "evidence": "The study discovered that APFs form after tau oligomer formation and bypass higher NFT aggregate formation",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 11,
      "target": 9,
      "key": "12046571e5247bbac0483e331887e3077e54d5061dc8f8db4d8147ba3cd1ab5921f65130a140997918060d525d458142703a400fa87972e294062c23d83afa80"
    },
    {
      "line": 397,
      "relation": "decreases",
      "evidence": "Oligomeric tau intermediates decrease cell viability (Flach et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 11,
      "target": 37,
      "key": "a5de6b85b6bebfcf50dfa34f920f60d04f70b0d7a423a1243505518d848d98592eff05b1ea10453bb5d9d287b4cb730a7d98a6ac31a21fd6a1666e4010575419"
    },
    {
      "line": 419,
      "relation": "association",
      "evidence": "Recently, data has shown that injected tau oligomers colocalize with the mitochondrial marker porin, suggesting a pathological relationship",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 11,
      "target": 60,
      "key": "cc31f639fdaea9ef154549055dbbd73f231d051f9e5e9db749d47a0c75bce4be9fe9c7abca68b6a894f2d3a3433e5a9181731d13647b1c6edd043061008d7747"
    },
    {
      "line": 425,
      "relation": "decreases",
      "evidence": "In fact, tau oligomers might disrupt microtubule stability and trafficking, thus affecting organelle distribution",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 11,
      "target": 4,
      "key": "f2006f4f672486deb533060f8d035026bbdbc30d7e6f0448c19791e7e09a7be0a217f8a3b5bec5964e940716ec2148b11770c2655f8a86ea29b6879f081a9d3b"
    },
    {
      "line": 431,
      "relation": "decreases",
      "evidence": "Also, data shows low levels of complex I in brain hemispheres injected with tau oligomers when compared to brains injected with monomers or fibrils",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 11,
      "target": 16,
      "key": "97ff41a62cf7eaf6e858ea18ecbc0dca7ea5064fbdc2e6e684da0217ae2f57b9c322a5cd9ad40fdfd441b737a820a102a2112df96cd1bd0e0f1812aa49f8d03f"
    },
    {
      "line": 438,
      "relation": "decreases",
      "evidence": "These results imply that tau oligomers initially affect complex I activity and may directly or indirectly disturb the later stage of complex V ATP synthesis (Lasagna-Reeves et al., 2011)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 11,
      "target": 16,
      "key": "a5a573c2ec51944f983acbc2a42d930a260121b887f53fa8e889249b1a097b1b4094af6729329f5dac2d51414dccfeae5a3024dfa7856e27686de51be3686891"
    },
    {
      "line": 439,
      "relation": "decreases",
      "evidence": "These results imply that tau oligomers initially affect complex I activity and may directly or indirectly disturb the later stage of complex V ATP synthesis (Lasagna-Reeves et al., 2011)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 11,
      "target": 20,
      "key": "f30c1d1300c7c90796c2967c8a593dadb6a9eb5a5e9309f19e172668a5e3b3dbba612654ddc6746119d77a5d76ccc666e889d2d3360918586fbc9d64211f5bf6"
    },
    {
      "line": 445,
      "relation": "increases",
      "evidence": "Hemispheres injected with tau oligomers were found to have increased levels of caspase-9 activation (Lasagna-Reeves et al., 2011)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 11,
      "target": 49,
      "key": "bc9a67a1ef34f055720c71e59d174757e54137ca57b1376aec4764024a15621bc2e4453ef8b2d58afefd646f6d1282e1461b0240dc85f58834d837a7a2b4d9c2"
    },
    {
      "line": 453,
      "relation": "increases",
      "evidence": "Suggestively, as tau oligomers concentrate at the mitochondrial membrane, cytochrome C is released, leading to caspase-9 activation via a complex with apoptotic-peptidase activating- factor-1 (Apaf-1; Li et al., 1997)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Mitochondrial Membranes": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 11,
      "target": 52,
      "key": "c58519cad0f25ba7fc4c0ea989330d9868070534ebb87582ea77f96cfca109cac095384f98496f839aa43201d8830c125f200e6d0aa75d49ae372ee8c0a57665"
    },
    {
      "line": 103,
      "relation": "increases",
      "evidence": "Hyper-phosphorylated tau assembles into small aggregates known as tau oligomers in route of NFT formation",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 57,
      "target": 11,
      "key": "6ef9891466ef495b4cefbb56662d7f171e6302008a4aeaa71a75ad5462ecbb918411ce6483cf127078623f527e90ee035067f976cbf885b5da5c434e0fcfc4aa"
    },
    {
      "line": 111,
      "relation": "increases",
      "evidence": "As hyperphosphorylated tau dislodges from microtubules, its affinity for other tau monomers leads individual tau to bind each other, forming oligomeric tau, a detergent-soluble aggregate",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 57,
      "target": 11,
      "key": "eded8ee7f98b3f5218783be1aacc9f3b72da77b3d2632cedf9c6fa0bae3663e51729b9006e83a79440c7e221cd02a0df1793b392d5d2788b726a1e3fcb17f710"
    },
    {
      "line": 104,
      "relation": "increases",
      "evidence": "Hyper-phosphorylated tau assembles into small aggregates known as tau oligomers in route of NFT formation",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 57,
      "target": 3,
      "key": "18e527b5a1b3b28a5977aa4c07d5403c9425d3ac5b842ed053b0d4fc9db7da4b35059d8512bd783adebb6d25aaa78f0aa9a95c62872a46153a997ffe1555144f"
    },
    {
      "line": 134,
      "relation": "increases",
      "evidence": "As these granular tau oligomers fuse together, they form tau fibrils, which ultimately form NFTs (Takashima, 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 14,
      "target": 10,
      "key": "50b5e304970119a4f303f85564f57e03045849700a9644f0c33d08f149186a14f32d119a9958e5bdf7f95ce2ee80e3cfd800d37ab542b1656740825cbc84fc69"
    },
    {
      "line": 135,
      "relation": "increases",
      "evidence": "As these granular tau oligomers fuse together, they form tau fibrils, which ultimately form NFTs (Takashima, 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 10,
      "target": 3,
      "key": "3e341f3a3caf972141f23cfaf08010507324602cc468338ce2a67f6d399a7e6d3722c39c7abdef54bef337a6ed3de8220dc471a7eb8b3484a23654d84b97f1b2"
    },
    {
      "line": 143,
      "relation": "positiveCorrelation",
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 66,
      "target": 11,
      "key": "be8c144ea0d66f2101652aca6c2abe174d5739971b0d94884838d461c023174387d0001024368c1224f8f390a7b7aa83bc236afb9b173d76d8b0094ca01a4c6c"
    },
    {
      "line": 405,
      "relation": "decreases",
      "evidence": "In aging, a protein involved in mitochondrial fission, dynamin-related protein 1 (DRP1), can bind tau abnormally, inducing neurodegeneration via mitochondrial dysfunction (Figure 2; DuBoff et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 27,
      "target": 36,
      "key": "6358f71810931dd7bd4e34b07fef71844a14637e71eb41614c5f3586cccf9d6fe231bcbc3c23b27cf59b6c16bf2bca5d1cd3dc1144a2097b1b2bded77431e492"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 18,
      "key": "1885712ad820d6d410a92ea0add0582c1a0ffc31febe8e833119d35a0d35d5f9a445fe618e47c46585df7e59c644c5da8f1873189d2318704f4e939b9df599c8"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 54,
      "key": "d04689950c5a6dee84908f64a2858e482723bcf4df3d24148c588f30021d37143ba07ec924d9f4963e28d06fdfccc45518550ddb3831ec37535b9c18a33416ab"
    },
    {
      "line": 200,
      "relation": "association",
      "evidence": "This hints that tau plays a role in monitoring intracellular signaling pathways (Pooler and Hanger, 2010)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 25,
      "target": 54,
      "key": "deac60d44a8701b2f4793373a837fd738cc4f362b988dac11ce18789d99ea86043075067d8a24e9f5a281c15035420be66d73446af149a653cbc9c5e8521bb3d"
    },
    {
      "line": 224,
      "relation": "association",
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "axon"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "cell body"
          }
        }
      },
      "source": 39,
      "target": 54,
      "key": "a25c605f6a1d07e267f94d59aa10625f19022992eed0a45ce12984f2c086a1b14c5d31de12439b035d1ce89cbe714c2cc9f3ff8247c652c362f5a35a7b8e1c30"
    },
    {
      "line": 225,
      "relation": "association",
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "axon"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "dendrite"
          }
        }
      },
      "source": 39,
      "target": 54,
      "key": "14c92fa6c9d86936a3847036a245fb4de50607334b3e3d05d66fa663aea969984e422fb1b3497ac9e244234e7225ff6bdf133b8aea825b6af2d82074de7b0bf1"
    },
    {
      "line": 233,
      "relation": "increases",
      "evidence": "A recent study showed that neuronal networks facilitate cell-to-cell transfer of tau via synapses; using a microfluidic device they demonstrated that decreasing synaptic connections weakens tau transfer and the subsequent aggregation on the acceptor cell (Calafate et al., 2015)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "cell"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "cell"
          }
        }
      },
      "source": 38,
      "target": 54,
      "key": "553ee63a9ca6783d53362b30418aec85c19c3089d81c1c25aeee57eb8b8f72e1743a1f3b187a6d83e77f45f9dc97b6e5f595e88f35955ef343e13a8ff3023c91"
    },
    {
      "line": 234,
      "relation": "association",
      "evidence": "A recent study showed that neuronal networks facilitate cell-to-cell transfer of tau via synapses; using a microfluidic device they demonstrated that decreasing synaptic connections weakens tau transfer and the subsequent aggregation on the acceptor cell (Calafate et al., 2015)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        }
      },
      "source": 38,
      "target": 8,
      "key": "5e012b5ea14ea149c67b27405eca706bd3b788d69dd10c505f33150362626579025a494b59c500f5b3c84c0b463b67742d00217ce906e9aa4d7b4fbf69a04690"
    },
    {
      "line": 248,
      "relation": "association",
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 19,
      "target": 54,
      "key": "8bee6d35eea4d01e07c7ec56d5089037b9806f8109d96aeae8f52d46f47776785b6f2d76423d115bd47eb12c1ccb00eb5f1219a31ecc179cf5fd933b5143e35b"
    },
    {
      "line": 257,
      "relation": "association",
      "evidence": "AD brain samples contain exosomal proteins within amyloid plaques hinting that exosomes play part in disease pathology (Rajendran et al., 2006)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 19,
      "target": 65,
      "key": "b234a27012985d99d8a0babed88fa0464cae011adfa1031e7a1c1c9c418eb2cde7c3ee72d2c3acef1876a77bc3f9cf4d1207d2fc55f723343f2e75170e69a44c"
    },
    {
      "line": 265,
      "relation": "association",
      "evidence": "In support, tau associated with exosomes and phosphorylated at Thr-181 (AT270+ tau) has been identified in human CSF samples of AD patients",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 19,
      "target": 59,
      "key": "73ba1c4af614abc06b8446803e10765fe6a68f8670f27122ce078326d756b9aadfdccf7e4cc31a137dff16314d787739c7b9576373303928fb0e8a6d07c9f766"
    },
    {
      "line": 249,
      "relation": "association",
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 5,
      "target": 54,
      "key": "ec5f938eb13d45fc55243f15107f51f21682eac244a804257805a9187459497f5066aac4ef99ca90e8d3d46cebbbbfddd9927d26ca3c9219fd730414ab21fab6"
    },
    {
      "line": 293,
      "relation": "regulates",
      "evidence": "Significantly, evidence suggests that tau secretion is partly mediated by ectosomal vesicles and that pathological tau accumulation in cells leads to a deviation toward tau secretion by exosomal vesicles (Dujardin et al., 2014a)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 5,
      "target": 54,
      "key": "18d43d69a6a5f0be459febaa1548a6c84531037937eec3fe71a7dd33301686a4dc5a6bf7a72db7609f8d0f45628af2efcfeb497245c78d0930f74f8b3a3e81f2"
    },
    {
      "line": 257,
      "relation": "association",
      "evidence": "AD brain samples contain exosomal proteins within amyloid plaques hinting that exosomes play part in disease pathology (Rajendran et al., 2006)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 65,
      "target": 19,
      "key": "9b04352ebd670dbdc9b49a828150a07c0a63d8ab072061b90fca78bdc025ed7f93ea21711f685555f485050f30ce2a8a3fde1cd9e4851815b28f6401a58e9a25"
    },
    {
      "line": 265,
      "relation": "association",
      "evidence": "In support, tau associated with exosomes and phosphorylated at Thr-181 (AT270+ tau) has been identified in human CSF samples of AD patients",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 59,
      "target": 19,
      "key": "61a268a152e8a38986e983af56da2e4e4459746a1071d8740a1069e740da760ad85a63936ffa41b84263096247246d3e7c1fc2411629b67725114c95a3ae2e4c"
    },
    {
      "line": 274,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 59,
      "target": 61,
      "key": "016edbddd12b8881312001f9ab30290e2af442a9993f9ff6852193669895d3569cd540942f85ada2253cf9eea2cca48efc86758f194319328a6548271e1d75d8"
    },
    {
      "line": 277,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 59,
      "target": 64,
      "key": "656a011e1a3536640eb0aea4e1c8e2cde69599472b76307adc4c9c169bfd373bf27715e661031ee08fcb47fc85d3e1b60b14a5ebfd31f008d05ffe4e1837cd0d"
    },
    {
      "line": 273,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 58,
      "target": 61,
      "key": "f3d8b16e02942648370cd73e08259a430879f4fe79fbb2660a970c4bed98fa99ba03948b6f5e68101b9388e2437d75bfe29de0e1a9d5b71e773d6b20a14df012"
    },
    {
      "line": 276,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 58,
      "target": 64,
      "key": "5a043796bebed0f02c3751888690da20e173f1ddafb60c2afe0e4f87d52d8d088623d8aba88dd02225333be92460c61c64b753025199204344ac15ab72e1c345"
    },
    {
      "line": 275,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 64,
      "target": 54,
      "key": "5e30ffa5aef20a942630ed9bfc99e7635729260bafaf14ced805529d648d45a0279f88ecf666ba7f305d188caff9d6e87b16b382cde461b84385dbec0c0ad86c"
    },
    {
      "line": 276,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 64,
      "target": 58,
      "key": "6e6e2633ab4e1f07c10dd327eb918bb9c47f87fdb6385af04ff1bb051c801605ecaaa86930d62c3c0824f9e3a20405aadf0965815619ced2d18ade39e264919f"
    },
    {
      "line": 277,
      "relation": "positiveCorrelation",
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 64,
      "target": 59,
      "key": "6dd632084ddbefe128b2c9653fc98f200ab2e23676aeb747954a3a928ce21e3ef075dd35b4fd7c0b27ff7cead3e32494858767992ed3986ee84d86c4f9cc6b67"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 7,
      "key": "d32712ec8170f909bd21fa8cb190c3ca76b639240c331265343fa103866dd88ddaa1559467e72e5026d366acbacd17c3353bf1f37cd5f754f22161a10043c66d"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 15,
      "key": "ac10c289660f710ef7023f0053905fcc9fcd9add52473daeb24e3c7176d490c197cfacf2610aae7edb494b5e56aecebf2534e4d2ae6ba84e93c413686fa90060"
    },
    {
      "line": 309,
      "relation": "increases",
      "evidence": "In the latter theory, during the secretion, vesicles and the cell membrane can be fused and uncoated tau protein can be released to the extracellular space (Clavaguera et al., 2009; Iba et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 41,
      "target": 54,
      "key": "25de4e3923a55a378271f07d0bbfd4e8f322face10d633554d7d9e6becb0093673a1078dc11c0c8dafa886a2ae964b584b312fe994313ff6f0916ea911a87ee6"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 50,
      "key": "9979f26fac7471b2840d671265e6e26e9c34ddb47854bf00b552f7483aed0ac16b2a902ffee6f2021a46b511ce11ee798dca16b33b345886836de59d00e33789"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 54,
      "key": "560b80c349c976739a10b38c8abb8ed216d24ee00a5d220e9167a0b0964ed008ad1a4d6cb07cb4f49048903f99637280cac217040eb06ec3f3629208f6154a9f"
    },
    {
      "line": 324,
      "relation": "increases",
      "evidence": "In other words, it is sensible to theorize that tauopathies progress via interaction of extracellular tau with M1 and M3 receptors on neurons leading to cytotoxic effects (Gómez-Ramos et al., 2009)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 45,
      "target": 68,
      "key": "1c9bda4f9fec47debcab67f4f161e96ff833cbbda09624512379ab0f231858a96d2618cddbec5fa9175d4ab8318e0b34201b9986d4b163800da051407eb61bf1"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 51,
      "key": "70f5455f715dde85741c93f938e5881862f313097012b480208474f55d84e7c43ea064c049695b5554ca8199317e38a59dd692f1c163192db258ada905c89d9a"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 54,
      "key": "a5d47ef7ff4dd6f7f291030eba0e41513532837d56d8a3cdf9528707dfdf8712f58e47884a4de73f6b464fa40a46875635c58cdf1701335a69690a112a8c7160"
    },
    {
      "line": 325,
      "relation": "increases",
      "evidence": "In other words, it is sensible to theorize that tauopathies progress via interaction of extracellular tau with M1 and M3 receptors on neurons leading to cytotoxic effects (Gómez-Ramos et al., 2009)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 46,
      "target": 68,
      "key": "cb635c677dbb65b229f58e083a9c476fe5db71480c5168052d83270d16f2258a1724e1fddac5531504b0ab21622b3513076e645a24fc3421d14b573fe72fa3d6"
    },
    {
      "line": 333,
      "relation": "association",
      "evidence": "Evidence shows that tau aggregates colocalize with dextran and HeLa cells, hinting that internalized aggregates are transported in endosomal vesicles and passed through the endosomal pathway to lysosomes (Wu et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 1,
      "target": 8,
      "key": "282ab0de3d301517e9234a32e72c21e3a586319b87e92fe7faba1c72ba2fa4276a2ae4bea1b5f598f32e39be9570173b427cea208b5db2323ec036d63aef3b99"
    },
    {
      "line": 334,
      "relation": "increases",
      "evidence": "Evidence shows that tau aggregates colocalize with dextran and HeLa cells, hinting that internalized aggregates are transported in endosomal vesicles and passed through the endosomal pathway to lysosomes (Wu et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "endosome"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "lysosome"
          }
        }
      },
      "source": 33,
      "target": 8,
      "key": "5a152ee04f7bd9a2e32cd4f838c8c356eb47cfcbbee3eed158f2bc119745105424ce7b8fbbdf90f8443eb61c7273e07a398c42e69490f5d6b4b0b98877d2443b"
    },
    {
      "relation": "hasComponent",
      "source": 42,
      "target": 8,
      "key": "75be5049c7090ecc0c2dc417af5688347a477fc984cc9ede4537b5f489a2088f48b133782e84a8f2f7f23a807bf985f637372eca7c168d7b61af21e5abe71160"
    },
    {
      "line": 340,
      "relation": "increases",
      "evidence": "Previous studies suggest that uptake of aggregated tau from the extracellular space depends on interaction with heparan sulfate proteoglycans (HSPGs; Holmes and Diamond, 2014)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "intracellular part"
          }
        }
      },
      "source": 42,
      "target": 8,
      "key": "fb780a69ea08dd3451b2222921971aea3e9b0bc6cd48f6ebe86e1bb657d9214219c24fa69a127cb8b2b8423da987557eadd2c52c1ed87c30fa5cb4ac8970e023"
    },
    {
      "line": 380,
      "relation": "increases",
      "evidence": "Basically, pathogenic tau aggregates use HSPGs to bind the cell surface of a neuron. This actively stimulates macropinocytosis, leading to propagation of aggregates between cells in culture and aggregate uptake in vivo (Holmes et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 42,
      "target": 8,
      "key": "cbe49d68a5b12a7cd89c3ad1cc456ad107c6dc8049aac53e74881e89c8e29a51a29af9bab1673d7407a5b1955f53e447e61259345289bf36e699da13694bb77d"
    },
    {
      "relation": "hasComponent",
      "source": 42,
      "target": 17,
      "key": "1f3ece2468545cd616d38b64d5d4418abf345337731d414571007b76299c21e3429b63c14cc85d10260d0310ede3fa4b418bb9ff4f12a26a47818995b5e1c177"
    },
    {
      "line": 378,
      "relation": "increases",
      "evidence": "Basically, pathogenic tau aggregates use HSPGs to bind the cell surface of a neuron. This actively stimulates macropinocytosis, leading to propagation of aggregates between cells in culture and aggregate uptake in vivo (Holmes et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 42,
      "target": 40,
      "key": "f39c1d95921a41b04aa888b82943642168ca06ceb4f77f12edc9575763c96519c74c2eb85a6bd3fc6243fd803f256574369e96942a444e2145d48d6192f6b8ce"
    },
    {
      "line": 379,
      "relation": "increases",
      "evidence": "Basically, pathogenic tau aggregates use HSPGs to bind the cell surface of a neuron. This actively stimulates macropinocytosis, leading to propagation of aggregates between cells in culture and aggregate uptake in vivo (Holmes et al., 2013)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 42,
      "target": 34,
      "key": "582b1520d71167ab0c9b3aaa1eea6171d3e4781406841b3cf7cab138ef1c508b06e84607aa70a86a9cfa15039ddefa49e0d2bd321e6418a006123921b6d54017"
    },
    {
      "line": 347,
      "relation": "association",
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 17,
      "target": 28,
      "key": "f7f76ff7611e47b6182edc757af7008c2bc5774601a8b4aff04c88f9c1876bee63e654ebd1c78ee6bff8518c17541720d3df978ba28b62ccfb7dc241bc1a1ee2"
    },
    {
      "line": 348,
      "relation": "association",
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 17,
      "target": 13,
      "key": "f2493d549eef7b462b277afd005bf9d5c637993a848297faf38b97312dc1ff31534b694a9556773708b7ae35e05488690b486fed42b44fb639a9fb24d8d8bd52"
    },
    {
      "line": 349,
      "relation": "association",
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 17,
      "target": 63,
      "key": "cf019eef9fb1ef487ffae4de718cca23e71579ee836b2b944ee133a456ce26244b1a1ad84d9b51e44597a971863a9d0e3328f2db0ca0ad48d4f51976a4bcbf9f"
    },
    {
      "line": 355,
      "relation": "increases",
      "evidence": "Consistently, HSPGs have been implicated in amyloid as well as tau fibril formation in vitro, presumably facilitated by anionic moieties",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 17,
      "target": 10,
      "key": "1e01b1a6e0417a74adf566b29301b19b45f8cabfb18d82675e0f80032e2606932235fc189cf0c4b7ab3e4db7d8d689ac9bcd9fc8cfc93fdeaec8eabb8d2b681a"
    },
    {
      "line": 356,
      "relation": "increases",
      "evidence": "Consistently, HSPGs have been implicated in amyloid as well as tau fibril formation in vitro, presumably facilitated by anionic moieties",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 17,
      "target": 12,
      "key": "2fd15de9f84e2f0f4c93accf53e620aa8b99ee09cecd3de828b7b078e9d7b39195c89886f1228e2d1920a3e628d8f6dc01b3c470b65b550dd6d06a0ff25d84dd"
    },
    {
      "line": 364,
      "relation": "increases",
      "evidence": "However, regardless of the multiple “sizes” of tau aggregates that interact with the cell surface via HSPGs, it is likely that an assembly of at least three tau molecules is required to initiate endocytosis via HSPGs (Mirbaha et al., 2015)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 17,
      "target": 40,
      "key": "14980655ecfe72f914b4e2aa742d54d34ddbd54b5d6762358e211af22cd72634701df02dea8997e05c7ca6df09bf986ec835b3b90e4008a81e1824333ab7b793"
    },
    {
      "line": 370,
      "relation": "increases",
      "evidence": "In other words, the HSPGs serve as a receptor for the cellular uptake of tau, a critical step similar to prion-like propagation",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "intracellular part"
          }
        }
      },
      "source": 17,
      "target": 54,
      "key": "a909fc8cbc2b60aa755568a46cc0ee55cbdfbe27d7b8f39ce88d8b23feddeb7b6ca07125176cbc9fbeee3e8df34515e2aa49384ae3abb0b5f402c5eb79238cc8"
    },
    {
      "line": 347,
      "relation": "association",
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 28,
      "target": 17,
      "key": "2d5f3f5d3b2dbcc4de9480f426aaa4c6cc9955c1bc99dab6055cd54701ab68af958f7baf932718ff826abbab7d03f2549e3c15e98d4260cac59e6d8b0c2c5b8f"
    },
    {
      "line": 348,
      "relation": "association",
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 13,
      "target": 17,
      "key": "06b0b0aebe7c4fb1505bd3fd44e9fe683a0cdc4020d83e5594bcc38b9271e0ae9c70df5f686d0a36b0241e7edba1cfc2a9f3774e03cf4ca04746a4d09af1f6b1"
    },
    {
      "line": 349,
      "relation": "association",
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 63,
      "target": 17,
      "key": "e5a9b2d218358da0a18342bd457a7c362614379e15262ecc21354c0a59b853ea27248b73dce6a8c15782ed3fca2c945ef394bd542e4c637e4cd7a4f41a301ee8"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 2,
      "key": "400d0e48766dbe97de95460a67b99c9ba838c307fb943f46f47bac162b48683bb0a95d5aa613b5dbcf9e63a28eb4b8a93692194170cb924f0cebca5752cb7a0b"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 8,
      "key": "18ed22a80ca2caf4cdc201775ba3456d0d05e40c5ae6ef07c4bbe4182493c67e952cea831cc4336bf305a5fc70eb679b7fda3af8ed5d792206dd06b3df0bc74e"
    },
    {
      "line": 392,
      "relation": "association",
      "evidence": "Hence, tau APFs may play a significant role in tauopathies by linking pore formation to cell death",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 9,
      "target": 68,
      "key": "145e3a17acb1951a745d6cbfd1cb7466702a2d9beed690f90092ca1444bf32935e75bb16f5fc69738c42ea1e314f24e4e6db3fb4dffae2ca903827b9f48f64ea"
    },
    {
      "relation": "hasComponent",
      "source": 47,
      "target": 53,
      "key": "751884bb8eacd68806ddf327afa0e1f874723775854de6801eb718a225cb53048f62119cd9e5013921b0ee82e7f101e45ce77eb0078b839b0b318290c4d4290f"
    },
    {
      "relation": "hasComponent",
      "source": 47,
      "target": 54,
      "key": "2a42a13ba42d988bc6db68e85acdc715458cee63436e1f2cdf1cbd45125cd5e1b2f0fda3aee3ad2e6745c2e5457f0c6c2d34435d179cff85dec5b3aba51349fe"
    },
    {
      "line": 404,
      "relation": "increases",
      "evidence": "In aging, a protein involved in mitochondrial fission, dynamin-related protein 1 (DRP1), can bind tau abnormally, inducing neurodegeneration via mitochondrial dysfunction (Figure 2; DuBoff et al., 2012)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 47,
      "target": 36,
      "key": "346070b659464244a29964877cbc15c5b4b2b1ee17a2f0d9638f8d2910c08e228cb208af18fb39a632b97127402504437fd193f1b79b6ec02020f1928dc8b32d"
    },
    {
      "line": 413,
      "relation": "decreases",
      "evidence": "Another study showed that expression of tau (truncated at Asp-421 to mimic caspase cleavage) caused mitochondrial dysfunction (Quintanilla et al., 2009)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 55,
      "target": 27,
      "key": "7b7c4db1e7dd5337c7ba410e912adb4423a82de78a203f0b301799f8fa90855c0374f8bf3bd7bc95e58e35e1248c6728c11fae05261fba810ec3865c46f77ec3"
    },
    {
      "line": 414,
      "relation": "decreases",
      "evidence": "Another study showed that expression of tau (truncated at Asp-421 to mimic caspase cleavage) caused mitochondrial dysfunction (Quintanilla et al., 2009)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 56,
      "target": 27,
      "key": "f26b59852432d4debd9ef117283de6bf1a3a58c08a30fe151fa18f8bcddec31852b211f8dd72faf8eb244004a1f7936b674151542b9af2c214a14e45f0889645"
    },
    {
      "line": 419,
      "relation": "association",
      "evidence": "Recently, data has shown that injected tau oligomers colocalize with the mitochondrial marker porin, suggesting a pathological relationship",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Extracellular Space": true
        }
      },
      "source": 60,
      "target": 11,
      "key": "56e270061e3689bea288d88803fc310f4073843036db8ae7e9de0c1aab54022894f8def0a9ff5d6dcfc90d8f1a5ee85c744021128023704177a5d2068fa1b63f"
    },
    {
      "relation": "hasComponent",
      "source": 44,
      "target": 48,
      "key": "291e7e2e46cc45c2d8e4a81dd81d49e1886193e99d7feec30928dbd96de985072a3dbdd6259835fb302744b421d1ad3f508fa3f68ede7f9d1fa5d046aec07973"
    },
    {
      "relation": "hasComponent",
      "source": 44,
      "target": 52,
      "key": "0e4a68af9c3e7db42020aa7c4c675182971464c58484eaa2d66f538e8451966219cfa22b17958cc5cc5c58ea80c22a76ce1e01a23b8391bd397e29fd730e2a5d"
    },
    {
      "line": 454,
      "relation": "increases",
      "evidence": "Suggestively, as tau oligomers concentrate at the mitochondrial membrane, cytochrome C is released, leading to caspase-9 activation via a complex with apoptotic-peptidase activating- factor-1 (Apaf-1; Li et al., 1997)",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in aging neuroscience",
        "reference": "28420982",
        "title": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "volume": "9",
        "pages": "83",
        "date": "2017-01-01",
        "first": "Shafiei SS",
        "last": "Castillo-Carranza DL",
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ]
      },
      "annotations": {
        "PublicationType": {
          "Review": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "CellStructure": {
          "Mitochondrial Membranes": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 44,
      "target": 49,
      "key": "8185200e2db106b48dbae691b21f30e425dc27b5f6d84fd8d7616bc3c7458fb51ddf2b50b5b2c52149481ee00a26b933828eb058456dbba4d6a41a3c0aa0717f"
    }
  ]
}